These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6218576

  • 1. Moxalactam in serious infections: clinical, bacteriologic, and pharmacokinetic studies.
    Giamarellou H, Tsagarakis J, Daikos GK.
    Rev Infect Dis; 1982; 4 Suppl():S629-38. PubMed ID: 6218576
    [Abstract] [Full Text] [Related]

  • 2. A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.
    Fitzpatrick BJ, Standiford HC.
    Pharmacotherapy; 1982; 2(4):197-212. PubMed ID: 6221237
    [Abstract] [Full Text] [Related]

  • 3. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE.
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Moxalactam therapy for a wide spectrum of bacterial infections in adults.
    Tofte RW, Rotschafer J, Solliday J, Crossley KB.
    Antimicrob Agents Chemother; 1981 May; 19(5):740-4. PubMed ID: 6457555
    [Abstract] [Full Text] [Related]

  • 9. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
    Digranes A, Benonisen E, Dibb WL, Ostervold B.
    Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
    Snepar R, Poporad G, Romano J, Levison ME.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):642-7. PubMed ID: 6459763
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S.
    Rev Infect Dis; 1982 Nov; 4 Suppl():S501-10. PubMed ID: 6218559
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O, Fabricius K, Krueger E, Rueckert U.
    Rev Infect Dis; 1982 Nov; 4 Suppl():S688-91. PubMed ID: 6218584
    [Abstract] [Full Text] [Related]

  • 16. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M, Dickgiesser N, Müller S, Wundt W.
    Arzneimittelforschung; 1981 Nov; 31(10):1677-81. PubMed ID: 6274361
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J, Vittecoq D, Decazes JM, Wolff M, Meulemans A.
    Presse Med; 1983 Jan 22; 12(3):139-42. PubMed ID: 6220351
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
    Eickhoff TC, Ehret J.
    Antimicrob Agents Chemother; 1981 Mar 22; 19(3):435-42. PubMed ID: 6264845
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.